Abivax (ABVX) Dividends Paid - Common (2024 - 2026)

Abivax (ABVX) posted quarterly Dividends Paid - Common of $558.9 million for Q1 2026, up 413.03% year-over-year from $108.9 million in Q1 2025, and down 9.58% quarter-over-quarter from $618.1 million in Q3 2025.

Abivax (ABVX) Dividends Paid - Common (2024 - 2026) Analysis & Trends

Abivax's Dividends Paid - Common history runs 3 years deep, the most recent figure standing at $558.9 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 96.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 34.60 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Abivax 9.39 Bn 9.39 Bn - 558.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 558.94 Mn
Mar 31, 2026 558.94 Mn
Sep 30, 2025 618.15 Mn
Sep 30, 2025 618.15 Mn
Jun 30, 2025 -48.26 Mn
Jun 30, 2025 -48.26 Mn
Mar 31, 2025 108.95 Mn
Mar 31, 2025 108.95 Mn
Sep 30, 2024 -45.98 Mn
Sep 30, 2024 -45.98 Mn
Jun 30, 2024 -20.77 Mn
Jun 30, 2024 -20.77 Mn
Mar 31, 2024 262.47 Mn
Mar 31, 2024 262.47 Mn